Paradoxical reactions to biologics provide insight June 15, 2017By John JesitusParadoxical reactions to biologic treatments can provide clues into related conditions such as granulomatous diseases, genetic polymorphisms and latent infections, says an expert.
In this issue
Biologic class differentiators June 15, 2017By Lisette HiltonDermatology experts offer insight into differentiating factors among TNF-alpha inhibitors, the IL 12/23 antagonist, IL 17 inhibitors and an oral option that carry considerations for managing certain patients. A peek at the pipeline June 15, 2017By Lisette HiltonThere is tremendous excitement surrounding IL-23 inhibitors for the treatment of psoriasis. Three are currently in the pipeline. Dupilumab maintains long-term benefits in atopic dermatitis July 11, 2017By John JesitusLong-term data for dupilumab in atopic dermatitis revealed at the American Academy of Dermatology (AAD) 75th Annual Meeting reflect safety, rapid relief of troublesome symptoms and a long-lived response in keeping with the drug’s breakthrough status, experts told Dermatology Times. Pain control benefits HS patients July 11, 2017By Bob KronemyerAdalimumab (Humira, AbbVie) enhances both health-related quality of life and work productivity in patients with moderate-to-severe hidradenitis suppurativa, according to the results of two phase 3 clinical trials.
Nitric oxide cream in pipeline July 12, 2017By Bob KronemyerA nitric oxide-releasing cream to treat psoriasis and atopic dermatitis is in development.
Prescribing barriers July 12, 2017By Lisette HiltonDermatologists who plan to prescribe brodalumab may face a rough road.
Trends in cosmeceutical ingredients June 07, 2017By Lisette HiltonVivian Bucay, M.D. reviewed the latest findings around common ingredients in today’s cosmeceutical formulations.
Choosing the best filler for the job June 09, 2017By Lisette HiltonToday’s abundance of filler choices might seem overwhelming, but one expert sees the growing product pallet as a way to refine results.
What is a nourishing hair shampoo?The word “nourishing” is truly a cosmetic term with no medical meaning; nevertheless, consumers ascribe a positive meaning to this term. Is it good to oil hair?Hair oil can also be used to relax the curl and frizz in kinky hair and to smooth frizzy straight hair. Does hair dyeing facilitate hair loss?Hair dyeing does not inhibit hair growth, but it may cause hair loss by damaging the hair that is color treated. Fitting in July 10, 2017By John JesitusThe approval of dupilumab (Dupixent, Sanofi Regeneron) for moderate-to-severe atopic dermatitis adds a much-needed option that may alter the broader course of atopic disease, experts told Dermatology Times. East Asian patient concerns July 10, 2017By Bob KronemyerThere are both unique nuances and cultural considerations to rejuvenating the skin of East Asian patients, according to one dermatologist. A new look at male chest fat July 12, 2017By Lisette HiltonA new application of cyolipolysis proves to be an effective non-invasive option in the treatment of pseudogynecomastia, according to study.
Teledermatology viable for skin cancer diagnosisTeledermatology may play a role in skin cancer diagnsosis, an accumulating body of literature indicates, says one dermatologist. SKs concern patients June 29, 2017By Lisette HiltonA recent study suggests patients are bothered by seborrheic keratoses and are inclined to want the lesions removed. Dermatologist Gary Goldenberg talks about a new option in the pipeline and how best to treat these lesions with available therapies. Multispecialty collaborationCollaboration with specialists in other fields can improve outcomes for patients with skin cancer, and it can be personally and professionally rewarding for the dermatologist, according to one expert.
5 reasons for a practice investigation June 10, 2017By Lisette HiltonAn increase in investigations primarily impacts surgeons and cosmetic dermatologists who serve as medical directors to medical spas outside of their own practices. This is what to know.
Patient education July 11, 2017By Cheryl BiseraIn our last article “Building a Patient Education Program” (May, page 82) we explored how a solid patient education program can keep patients, resources and revenue from falling through the cracks and what your practice needs to build a strong patient education program.
Stand out July 12, 2017By Lisette HiltonIt’s important that cosmetic dermatologists market to promote their practices. But, today, it’s vital they market to promote the common good — of the cosmetic medicine industry, that is.
Blindspots to success July 12, 2017By Lisette HiltonCosmetic practices have all the bells and whistles —from new technologies to skilled practitioners. So, why are so many competing on price? Combat commoditization July 12, 2017By Lisette HiltonThe problem in the aesthetic marketplace is everyone offers the same thing, in the same way and says the same things, says one expert. Business principles in dermatology practice July 13, 2017By Lisette Hilton“Business literacy is an emerging competency that’s necessary for physicians,” says one dermatologist.
Treating eczemas in skin of color June 19, 2017By Bob KronemyerWhen it comes to treating atopic dermatitis in non-white racial ethnic groups, there are variations in prevalence, genetic factors and clinical presentation.
Considerations when treating children with lasers July 06, 2017By Karen AppoldA laser is a suitable mode of treatment for certain dermatologic conditions in pediatric patients; however, there are certain procedural aspects that physicians should consider when treating younger children.
Revenue boosters July 07, 2017By Lisette HiltonDermatologists trying to boost practice revenue might add a device in hopes of making a profit on a cosmetic option or a skincare product line sold through the practice.
Adverse Reactions Associated with Biologics for Moderate-to-Severe Plaque Psoriasis
July 01, 2017In July, our table of the month sums up biologics approved for moderate-to-severe plaque psoriasis and common adverse events associated with these biologics.